User:Mr. Ibrahem/Esmolol

Esmolol, sold under the brand name Brevibloc among others, is a medication used to treat supraventricular arrhythmias, high blood pressure, and myocardial ischemia. It is given by injection into a vein. Onset of effects can begin within a minute and last for up to 30 minutes.

Common side effects include low blood pressure, sweating, headache, nausea, and inflammation at the site of injection. Other side effects may include swelling, pulmonary edema, and urinary retention. It is a cardioselective beta1 receptor blocker which inhibits the sympathetic nervous system. It is a class II antiarrhythmic.

Esmolol was patented in 1980 and approved for medical use in 1986. It is available as a generic medication. In the United Kingdom it costs the NHS about £10 per 100 mg vial. In the United States this amount is about 6 USD as of 2021.